Investigation

ROSEN, A LEADING NATIONAL FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI

Retrieved on: 
Monday, March 11, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, March 9, 2024

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • For more information on the Chemours investigation go to: https://bespc.com/cases/CC
    On February 20, 2024, Methanex issued a press release “announc[ing] .
  • The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”).
  • For more information on the Inari Medical investigation go to: https://bespc.com/cases/NARI

NARI INVESTOR NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI

Retrieved on: 
Tuesday, March 5, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation – NARI

Retrieved on: 
Saturday, March 2, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=22855 or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

INARI MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inari Medical, Inc. on Behalf of Inari Medical Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, March 1, 2024

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI) on behalf of Inari Medical stockholders.

Key Points: 
  • NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI) on behalf of Inari Medical stockholders.
  • Our investigation concerns whether Inari Medical has violated the federal securities laws and/or engaged in other unlawful business practices.
  • Click here to participate in the action.
  • The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”).

Blank Rome Adds Leading White Collar Team, Continuing Nationwide Expansion

Retrieved on: 
Monday, February 26, 2024

The group’s arrival continues the strategic expansion of Blank Rome’s White Collar Defense and Investigations group.

Key Points: 
  • The group’s arrival continues the strategic expansion of Blank Rome’s White Collar Defense and Investigations group.
  • In January, five white collar attorneys from litigation boutique Spears & Imes joined Blank Rome in New York, including partners David Spears , Linda Imes , and Chris Dysard .
  • In November 2023, Barrett R. Howell joined the White Collar Defense and Investigations group as a partner in the firm’s recently opened Dallas office.
  • They focus on white collar defense litigation, government investigations and enforcement actions, international disputes and arbitration, internal investigations, and advising clients on compliance programs, voluntary disclosures, and remediation.

Tingo Group, Inc. to File Form 25 to Voluntarily Delist its Common Stock from the Nasdaq Stock Market

Retrieved on: 
Tuesday, February 20, 2024

MONTVALE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”) today announced that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Stock Market (“Nasdaq”).

Key Points: 
  • MONTVALE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Tingo Group, Inc. (NASDAQ: TIO) (“Tingo” or the “Company”) today announced that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Stock Market (“Nasdaq”).
  • The Company’s audit committee reduced to two members on December 20, 2023, following the resignation of Mr. Jamal Khurshid.
  • Having carefully considered the above non-compliance matters together with other factors, and consulted with Nasdaq, the Company’s Board of Directors (the “Board”) has decided it is in shareholders’ best interests to file Form 25 and voluntarily delist from Nasdaq.
  • Once the investigation has been completed, and any appropriate actions taken, the Company will consider reapplying for a listing on Nasdaq or another major stock exchange.

Former Federal Prosecutor Seth Goertz Joins Dorsey in Phoenix

Retrieved on: 
Tuesday, March 5, 2024

Dorsey & Whitney LLP continues the expansion of the Phoenix office and its nationally recognized Government Solutions & Investigations group with the arrival of former federal prosecutor Seth Goertz , the law firm announced today.

Key Points: 
  • Dorsey & Whitney LLP continues the expansion of the Phoenix office and its nationally recognized Government Solutions & Investigations group with the arrival of former federal prosecutor Seth Goertz , the law firm announced today.
  • View the full release here: https://www.businesswire.com/news/home/20240305604950/en/
    Dorsey & Whitney LLP continues the expansion of the Phoenix office and its nationally recognized Government Solutions & Investigations group with the arrival of former federal prosecutor Seth Goertz.
  • “We are excited to welcome Seth to our Phoenix office.
  • Seth advances the strategic growth of the firm’s Government Solutions & Investigations team by adding white-collar defense and government investigation capabilities in Phoenix.

Greg Finning Joins Holovach & Co. as Managing Director of Investigations & Special Projects

Retrieved on: 
Tuesday, March 5, 2024

Holovach & Co., an independent investigations and private security firm, is pleased to announce that Greg Finning has joined the firm as Managing Director of Investigations & Special Projects.

Key Points: 
  • Holovach & Co., an independent investigations and private security firm, is pleased to announce that Greg Finning has joined the firm as Managing Director of Investigations & Special Projects.
  • Mr. Finning brings over two decades of experience in both the private and government sectors, leading multi-jurisdictional investigations involving complex disputes, fraud investigations, internal investigations on behalf of private equity firms and pharmaceutical companies, litigation support, due diligence, and asset tracing investigations both in the US and internationally.
  • Prior to joining Holovach & Co., Mr. Finning was the Director of Investigations at a global investigations and business intelligence firm.
  • Over the course of his career, he has led complex cross-border multi-jurisdictional money laundering and narcotics trafficking investigations of transnational criminal organizations.

Secure India Selects Reveal as Legal AI & eDiscovery Partner to Supercharge Capabilities

Retrieved on: 
Friday, March 1, 2024

This collaboration signifies Secure India’s dedication to pioneering advanced data solutions, employing AI-centric methods for eDiscovery, Legal Review, and Investigation.

Key Points: 
  • This collaboration signifies Secure India’s dedication to pioneering advanced data solutions, employing AI-centric methods for eDiscovery, Legal Review, and Investigation.
  • Secure India offers state-of-the-art eDiscovery, Cyber Intelligence, and Digital Forensics Solutions.
  • The future is AI and Reveal is the right technology to take the lead in the eDiscovery field.
  • “As Reveal continues to expand our operations in India and across the APAC region, we are excited to partner with Secure India, a company that aligns with our vision for redefining success in eDiscovery, review, and investigations through advanced legal technology," said Wendell Jisa, Founder & CEO of Reveal.